A phase 3 trial of inotuzumab ozogamicin for high-risk B-ALL: Second safety phase results from Children's Oncology Group AALL1732

被引：0
|
作者：
O'Brien, Maureen Megan
McNeer, Jennifer Lynn
Rheingold, Susan R.
Devidas, Meenakshi
Chen, Zhiguo
Bhojwani, Deepa
Ramsey, Laura B.
Agrawal, Anurag
Wood, Brent L.
Suh, Eugene
Alexander, Sarah
Miller, Tamara P.
Militano, Olga
Burke, Michael
Salzer, Wanda L.
Raetz, Elizabeth A.
Loh, Mignon L.
机构：
[1] Cincinnati Childrens Hosp Med Ctr, Cincinnati, OH USA
[2] Univ Chicago, Chicago, IL USA
[3] Childrens Hosp Philadelphia, Philadelphia, PA USA
[4] St Jude Childrens Res Hosp, Memphis, TN USA
[5] Univ Florida, Dept Biostat, Gainesville, FL USA
[6] Childrens Hosp Los Angeles, Los Angeles, CA USA
[7] UCSF, Benioff Childrens Hosp Oakland, Oakland, CA USA
[8] CHLA, Los Angeles, CA USA
[9] Loyola Univ, Med Ctr, Maywood, IL USA
[10] Hosp Sick Children, Toronto, ON, Canada
[11] Emory Univ, Atlanta, GA USA
[12] Childrens Oncol Grp, Monrovia, CA USA
[13] Med Coll Wisconsin, Milwaukee, WI USA
[14] Uniformed Serv Univ Hlth Sci, Bethesda, MD USA
[15] Perlmutter Canc Ctr, New York, NY USA
[16] NYU Langone, New York, NY USA
[17] Seattle Childrens Hosp, Seattle, WA USA
来源：
JOURNAL OF CLINICAL ONCOLOGY | 2023年 / 41卷 / 16期
基金：
美国国家卫生研究院;
关键词：
D O I：
暂无
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
10016
引用
收藏
页数：1
相关论文
共 50 条
  • [31] Treatment of 11q23/MLL + AML with Gemtuzumab Ozogamicin: Results from the Randomized Phase Ill Children's Oncology Group Trial AAML0531
    Pollard, Jessica
    Alonzo, Todd A.
    Cerbing, Robert B.
    Raimondi, Susana C.
    Hirsch, Betsy A.
    Sung, Lillian
    Aplenc, Richard
    Guest, Erin M.
    Bernstein, Irwin D.
    Loken, Michael R.
    Meshinchi, Soheil
    Gamis, Alan S.
    BLOOD, 2015, 126 (23)
  • [32] CD33 Expression and Its Association With Gemtuzumab Ozogamicin Response: Results From the Randomized Phase III Children's Oncology Group Trial AAML0531
    Pollard, Jessica A.
    Loken, Michael
    Gerbing, Robert B.
    Raimondi, Susana C.
    Hirsch, Betsy A.
    Aplenc, Richard
    Bernstein, Irwin D.
    Gamis, Alan S.
    Alonzo, Todd A.
    Meshinchi, Soheil
    JOURNAL OF CLINICAL ONCOLOGY, 2016, 34 (07) : 747 - +
  • [33] Osteonecrosis (ON) is Associated with Improved Event Free Survival (EFS) in High-Risk Acute Lymphoblastic Leukemia (HR-ALL): Results of Children's Oncology Group (COG) Study AALL0232
    Mattano, L. A.
    Devidas, M.
    Chen, S.
    Raetz, E.
    Loh, M.
    Winick, N.
    Hunger, S. P.
    Carroll, W. L.
    Larsen, E.
    PEDIATRIC BLOOD & CANCER, 2017, 64 : S17 - S17
  • [34] Phase I trial of oral fenretinide in children with high-risk solid tumors: A report from the Children's Oncology Group (CCG 09709) (vol 24, pg 3423, 2006)
    Villablanca
    JOURNAL OF CLINICAL ONCOLOGY, 2006, 24 (25) : 4223 - 4223
  • [35] Outcomes with reduced intensity therapy in a low-risk subset of children with National Cancer Institute (NCI) standard-risk (SR) B-lymphoblastic leukemia (B-ALL): A report from Children's Oncology Group (COG) AALL0932.
    Schore, Reuven J.
    Angiolillo, Anne J.
    Kairalla, John A.
    Devidas, Meenakshi
    Rabin, Karen R.
    Zweidler-McKay, Patrick A.
    Borowitz, Michael J.
    Wood, Brent L.
    Carroll, Andrew J.
    Heerema, Nyla A.
    Relling, Mary V.
    Hitzler, Johann
    Lane, Ashley R.
    Maloney, Kelly W.
    Wang, Cindy
    Carroll, William L.
    Winick, Naomi J.
    Raetz, Elizabeth A.
    Loh, Mignon L.
    Hunger, Stephen
    JOURNAL OF CLINICAL ONCOLOGY, 2020, 38 (15)
  • [36] Feasibility of intensive post-Induction therapy incorporating clofarabine (CLOF) in the very high risk (VHR) stratum of patients with newly diagnosed high risk B-lymphoblastic leukemia (HR B-ALL): Children's Oncology Group AALL1131.
    Burke, Michael
    Devidas, Meenakshi
    Chen, Si
    Gore, Lia
    Larsen, Eric
    Hilden, Joanne M.
    Loh, Mignon L.
    Winick, Naomi J.
    Carroll, William L.
    Raetz, Elizabeth A.
    Hunger, Stephen
    Salzer, Wanda L.
    JOURNAL OF CLINICAL ONCOLOGY, 2015, 33 (15)
  • [37] Expression profiling identifies novel genetic subgroups with distinct clinical features and outcome in high-risk pediatric precursor B acute lymphoblastic leukemia (B-ALL). A children's oncology group study
    Harvey, Richard C.
    Davidson, George S.
    Wang, Xuefei
    Dobbin, Kevin K.
    Bedrick, Edward J.
    Wilson, Carla S.
    Atlas, Susan R.
    Kang, Huining
    Chen, I-Ming
    Hunger, Stephen P.
    Devidas, Meenakshi
    Carroll, William L.
    Bowman, Paul
    Camitta, Bruce
    Reaman, Gregory
    Willman, Cheryl L.
    BLOOD, 2007, 110 (11) : 428A - 429A
  • [38] A Phase 3 Trial of 2 Years of Androgen Suppression and Radiation Therapy With or Without Adjuvant Chemotherapy for High-Risk Prostate Cancer: Final Results of Radiation Therapy Oncology Group Phase 3 Randomized Trial NRG Oncology RTOG 9902
    Rosenthal, Seth A.
    Hunt, Daniel
    Sartor, Oliver
    Pienta, Kenneth J.
    Gomella, Leonard
    Grignon, David
    Rajan, Raghu
    Kerlin, Kevin J.
    Jones, Christopher U.
    Dobelbower, Michael
    Shipley, William U.
    Zeitzer, Kenneth
    Hamstra, Daniel A.
    Donavanik, Viroon
    Rotman, Marvin
    Hartford, Alan C.
    Michalski, Jeffrey
    Seider, Michael
    Kim, Harold
    Kuban, Deborah A.
    Moughan, Jennifer
    Sandler, Howard
    INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS, 2015, 93 (02): : 294 - 302
  • [39] Dexamethasone (DEX) versus prednisone (PRED) during induction for children with high-risk acute lymphoblastic leukemia (HR-ALL): A report from the Children's Oncology Group Study AALL0232.
    Winick, N. J.
    Salzer, W. L.
    Devidas, M.
    Nachman, J. B.
    Raetz, E. A.
    Loh, M. L.
    Heerema, N. A.
    Carroll, A. J.
    Gastier-Foster, J. M.
    Borowitz, M. J.
    Wood, B. L.
    Willman, C. L.
    Hunger, S.
    Carroll, W. L.
    Larsen, E. C.
    JOURNAL OF CLINICAL ONCOLOGY, 2011, 29 (15)
  • [40] Outcomes after Intermediate-Risk Relapse of Childhood B-Lymphoblastic Leukemia (B-ALL) and the Role of Allogeneic Stem Cell Transplantation (SCT): A Report from Children's Oncology Group (COG) AALL0433
    Lew, Glen
    Lu, Xiaomin
    Yanofsky, Rochelle
    Rheingold, Susan R.
    Whitlock, James
    An, Qi
    Devidas, Meenakshi
    Hastings, Caroline A.
    Winick, Naomi J.
    Carroll, William L.
    Borowitz, Michael J.
    Hunger, Stephen
    Pulsipher, Michael A.
    BLOOD, 2014, 124 (21)
12345